Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001833214-26-000003
Filing Date
2026-03-09
Accepted
2026-03-09 17:10:24
Documents
114
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sabs-20251231.htm   iXBRL 10-K 5442391
2 EX-21.1 sabs-ex21_1.htm EX-21.1 3478
3 EX-23.1 sabs-ex23_1.htm EX-23.1 4080
4 EX-31.1 sabs-ex31_1.htm EX-31.1 27303
5 EX-31.2 sabs-ex31_2.htm EX-31.2 27261
6 EX-32.1 sabs-ex32_1.htm EX-32.1 11413
7 EX-32.2 sabs-ex32_2.htm EX-32.2 11292
8 GRAPHIC img53764769_0.jpg GRAPHIC 333594
9 GRAPHIC img53764769_1.jpg GRAPHIC 249041
10 GRAPHIC img53764769_2.jpg GRAPHIC 248875
11 GRAPHIC img53764769_3.jpg GRAPHIC 502904
12 GRAPHIC img53764769_4.jpg GRAPHIC 63611
13 GRAPHIC img53764769_5.jpg GRAPHIC 84799
14 GRAPHIC img53764769_6.jpg GRAPHIC 87232
15 GRAPHIC img53764769_7.jpg GRAPHIC 65180
16 GRAPHIC img53764769_8.gif GRAPHIC 9557
17 GRAPHIC img53764769_9.jpg GRAPHIC 86711
18 GRAPHIC img53764769_10.jpg GRAPHIC 276716
  Complete submission text file 0001833214-26-000003.txt   23199225

Data Files

Seq Description Document Type Size
19 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sabs-20251231.xsd EX-101.SCH 2167027
117 EXTRACTED XBRL INSTANCE DOCUMENT sabs-20251231_htm.xml XML 3609726
Mailing Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140
Business Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140 305-845-2813
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39871 | Film No.: 26736070
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)